Log In
BCIQ
Print this Print this
 

MRG-107

  Manage Alerts
Collapse Summary General Information
Company miRagen Therapeutics Inc.
DescriptionMicroRNA-155 antagonist
Molecular Target MicroRNA-155 (miR-155)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: microRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today